• Provision Consulting Group

FDA warns Artri and Ortiga products, which may contain hidden drug ingredients

Jun 14 2022


FDA is warning consumers not to purchase or use products marketed with variations of the names “Artri” or “Ortiga” due to potentially dangerous hidden active drug ingredients not listed on the product label.


These products are promoted for treating arthritis, muscle pain, osteoporosis, bone cancer, and other conditions and are sold on various websites and in some retail stores.


FDA laboratory analyses revealed certain Artri and Ortiga products contain the undeclared drug ingredients:

  • Dexamethasone (a corticosteroid) that can cause serious adverse events, including infections, increased blood glucose (sugar) levels, changes in blood pressure, damage to bones, psychiatric problems, and adrenal dysfunction;

  • Diclofenac sodium (an anti-inflammatory drug) that can lead to adverse cardiovascular events, such as heart attack and stroke, or serious gastrointestinal damage, including bleeding, ulceration, and fatal tears of the stomach and intestines, or liver toxicity including liver failure that can cause the need for a liver transplant or death

  • Methocarbamol (a muscle relaxant) that can cause sedation, dizziness, and low blood pressure.


These drug ingredients, which are not listed on the product label, can also interact with other drugs a consumer is taking.


FDA has received adverse event reports, including of liver toxicity and death, associated with the use of Artri King products, since the agency issued its first warning about an Artri Ajo King product on January 5, 2022.


Suddenly stopping corticosteroids after long-term use or high doses can result in a serious withdrawal syndrome that includes fatigue, nausea, low blood pressure, low blood glucose levels, fever, dizziness, muscle and joint pain, and shortness of breath. These risks depend on several factors that a health care professional must assess. Medical intervention may be necessary.


FDA has identified the following Artri and Ortiga products containing hidden drug ingredients:

  • Artri Ajo King

  • Artri King

  • Ortiga Mas Ajo Rey

  • Ortiga Mas Ajo Rey Extra Forte


FDA analyses reflect only the undeclared ingredients discovered in one product from a specific lot, but ingredients may vary from product to product or from lot to lot. Products marketed as dietary supplements that are found to have hidden drug ingredients generally fail to comply with most current good manufacturing practices designed to ensure product quality and safety. Therefore, consumers should expect the manufacturing processes for Artri and Ortiga products are unreliable in providing consistent amounts of active ingredients or to prevent the introduction of unknown chemicals or other impurities.


FDA is investigating the distribution of these products in the United States and has advised certain companies not to sell or distribute these products. The agency may take additional enforcement steps that may include warning letters, seizure, injunction, or criminal charges.




Provision work professionally while meeting clients' needs.


We will streamline the regulatory processes so that our clients can utilize

their time and money most efficiently.


Experience the best FDA approval directions and solutions!



If you have questions about FDA regulation of medical devices

or importing of medical devices to the United States,

please CONTACT US.


Office 1-909-493-3276

Email ask@provisionfda.com







SOURCE :

https://www.fda.gov/drug_safety_and_availability